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Tejani et al. 3 reported success with a relatively short
(8-week) course of CyA 7 mg/kg/d in steroid-resistant or
dependent children with NS classified histologically as FGS,
IgM nephropathy and diffuse mesangial proliferative
nephritis. From this evidence a response to CyA might have
been expected in our 4 FGS patients; none responded or
even improved, 2 sUbsequently died, and 1 developed
chronic renal failure with profound tubular damage. Brodehl
et al." showed that CyA induced remission in steroid-
dependent MCD, but relapses recurred on withdrawal of the
CyA, and 50% of patients with steroid-resistant FGS
responded to CyA.
Sequential studies of patients on CyA have revealed a
decrease in the T4!T8 ratio, mainly due to a reduction in T4
cells." However, CyA also inhibits cytotoxic T lymphocytes.'6
CyA appeared to alter numbers of immunoregulatory cells in
this study, with changes in the T4!T8 ratios from normal. l7
The tentative implications otthis study are that CyA
should be used with great caution at lower dosages and
lower trough levels for the monitoring of the drug. In FGS, in
which prognosis can be poor and newer forms pf treatment
are needed, these early findings indicate that CyA is not
useful and may potentially be harmful.
Relapse of the NS on cessation of CyA therapy is an even
greater disadvantage in the South African black child, for
whom regular follow-up is a major difficulty. The use of a
potentially toxic drug such as CyA for MCD, which has an
excellent long-term prognosis, is difficult to justify.
From current knowledge it is now clear that steroid-
resistant children with NS are more likely to develop CyA-
induced nephrotoxicity,'8 and that the duration of therapy in
this study was far too long,'° thereby increasing this risk.
We thank Sandoz for providing the cyclosporin, Miss R.
Seetal for typing the manuscript, and the Superintendent of
King Edward VIII Hospital for permission to study the
patients. Professor M. Adhikari is in receipt of an MRC
grant.
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The risk of schistosomiasis
in Zimbabwean triathletes
A. K. Jeans, M. P. Schwellnus
A study was carried out to determine the risk of
schistosomiasis in triathletes in Zimbabwe. The
prevalence of schistosomiasis in 30 triathletes (24 males,
6 females) was compared with that in 24 non-triathlete
controls after the 1989/90 triathlon season. All the
subjects found to be infected were then treated with
praziquantel (40 mg/kg). The seasonal incidence of
schistosomiasis in triathletes was then determined in a
prospective study during the 1990/91 season.
Schistosomiasis was diagnosed by urine and stool
.microscopy for ova, blood eosinophil counts and
serological bilharzial fluorescent antibody tests for IgM
and IgG antibodies: There was a significantly (P < 0,05)
higher prevalence of schistosomiasis among the triathietes
(80%) than among the controls (38%). The seasonal
incidence of schistosomiasis was 64%. Exposure of
triathletes to fresh-water dam swimming in Zimbabwe
poses a significant risk for the development of
schistosomiasis.
S Afr Med J 1994; 84: 756-758.
In recent years the sport of triathlon (cycling, swimming and
running) in Zimbabwe has been characterised by an
increasing number of local and overseas competitors who
enter the major standard-distance triathlon events on the
national race calendar. In the 1989/90 season (October-
April) the 1,5 km swim legs of some of the major triathlon
events in Zimbabwe were moved away from chlorinated
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swimming pools to open bodies of fresh water, to
accommodate the increased number of entries. During the
1989/90 season these swimming events took place in one
water-filled quarry (October 1989), and four fresh-water
dams (December 1989 and January, March and April 1990),
and in the 1990/1991 season in the same mine quarry,
(October 1990) and two fresh-water dams (December 1990,
March 1991).
Reports from the local water authorities indicated that the
fresh-water dams were known to be potential sources of
schistosomiasis (bilharzia) because: (I) they were located in
areas where schistosomiasis is endemic; and (iJ) they were
shown to contain the fresh-water snail species that form
the intermediate host for Schistosoma mansoni and
S. haematobium.' The mine quarry did not have any snail
host species.
Humans may become infected with schistosomiasis by
bathing, wading or immersing limbs in infested fresh water.
The risk is increased if the water is slow-flowing, still or
shallow!" The severity of human infection is related to the
frequency and duration of such water contact.5-7 The
potential acute and long-term effects of schistosomiasis in
humans2.'.l2 were of concern to the race organisers. In
particular, overseas athletes who have never been exposed
to schistosomiasis were potentially at increased risk. 4.13 It is
important to note that physically active Zimbabweans
commonly have contact with fresh water through other
water-based recreational pursuits such as boating, angling,
windsurfing and water-skiing.
Specific precautions to decrease the risk of infection to
competitors were taken by the organisers of triathlon events
in Zimbabwe during the 1989/90 season. These consisted of
spraying molluscicide at the swim entry and exit points, and
confining the swim routes to relatively deep water. Despite
these ·precautions, cases of schistosomiasis were recorded
in triathletes during and after the 1989/90 season. However,
the extent of the problem was not documented.
The aims of this study were: (I) to document the
prevalence of schistosomiasis in the triathletes who
participated in the 1989/90 season; and (il) to determine the
incidence of schistosomiasis in triathletes competing in
fresh-water swims during- the 1990/91 season.
Methods
A sample of 30 triathletes (24 males, 6 females) was
randomly selected from those who had competed in all the
open fresh-water swims during the 1989/90 national
Zimbabwean triathlon season. A control group of 24 runners
(20 males, 4 females) who did not participate in triathlons
was randomly selected from members of a running club in
Harare. All the subjects were asked to complete a
questionnaire enquiring about other recreational activities in
fresh water, and whether they had recently (in the previous 4
months) been tested or treated for schistosomiasis. All the
subjects gave written informed consent to be tested for
schistosomiasis, and, if found to be positive, to be treated.
Six triathletes and 3 runners had been tested (in the
previous 4 months) and the results of these tests were
available. The remaining 24 triathletes and 21 runners in the
control group underwent laboratory testing for
schistosomiasis. The laboratory tests were conducted by
medical technologists at a private medical laboratory in
Harare. Blood samples, a midday urine specimen and a
stool specimen were taken from each of the subjects. A
serum bilharzia fluorescent antibody test (BFAT) for IgM and
IgG antibodies and a blood film eosinophil count were
performed. Microscopy for the detection of schistosoma ova
was conducted on the urine and stool specimens. The
criteria used in this study to diagnose schistosomiasis
infection are listed in Table 1. 14 The prevalence of
schistosomiasis in each group before the 1990/91 season
was taken as the percentage of subjects who tested positive
for schistosomiasis in each group.
Table I. Criteria for the diagnosis of schistosomiasis
One or more of the following constituted a positive diagnosis:
Positive BFAT for IgM antibodies
Schistosoma ova detected in urine
Schistosoma ova detected in stool
Positive BFAT for Ig8 antibodies (negative IgM) plus eosinophilia> 6%
The same sample of triathletes was studied over the
1990/91 triathlon season to determine the seasonal
incidence of schistosomiasis in Zimbabwean triathletes. To
establish a baseline whereby the triathletes would be free of
schistosomiasis at the start of the 1990/91 season,
triathletes who had tested positive (and had not already
been treated) were given a single oral dose (40 mg/kg) of
praziquantel 5 months before the start of the season. It has
been well documented that praziquantel is very effective in
the treatment of schistosomiasis in man.,s.l1 In the absence
of re-infection no ova can be detected in urine or stool, the
eosinophil count drops to < 6%, and BFAT (IgM) tests
become negative within 6 months of therapy."
Five months after treatment had been given to these
athletes and before the first open-water dam swim of the
1990/91 season, all 30 triathletes were again tested to
ensure that they were negative for schistosomiasis, using
the following criteria: (I) negative BFAT for IgM antibodies;
(iJ) no ova detected in urine or stool; and (iiJ) negative BFAT
for IgG antibodies, or positive BFAT for IgG antibodies but
no eosinophilia (defined as an eosinophil count of < 6%).
Three triathletes did not test negative and were therefore
excluded from the incidence study, leaving 27 who were
followed up during the 1990/91 season.
These subjects were asked not to engage in any fresh-
water contact other than designated open-water swims of
the 1990/91 triathlon season, until the completion of the
study. They were also requested to report any accidental
contact with possible infested fresh water. Two subjects
reported fresh-water contact other than the dam swims
during the triathlon season, and were excluded from the
study. The final group of triathletes in the incidence study
was therefore 25.
At the end of the 1990/91 season (June 1991), the 25
triathletes in the incidence study group were tested for
schistosomiasis (Table I). The seasonal incidence of
schistosomiasis was determined as the number of new
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Statistical analysis
The pre-season prevalence of schistosomiasis in the
triathlete group and the control group was compared using
the chi-square test. The level of statistical significance was
established at P < 0,05.
Results
The results of the laboratory tests for schistosomiasis over
the study period in the triathletes and controls are set out in
Table 11.
Table 11. Results of laboratory tests for schistosomiasis in the
triathletes and controls
Triatllletes Runners Triathletes Triathletes
(N= 30), (N=24), (N=30), (N= 25),
July 1990 July 1990 Dec 1990 July 1991
BFAT IgM +ve 21 8 2 15
BFAT IgG +ve and
eosinophilia> 6% 3 1 1 1
Ova in slool 1 1 0 0
Ova in urine 0 0 0 0
The prevalence of schistosomiasis before the onset of the
1990/91 season in the triathletes (80%) was significantly
higher (P < 0,05) than that in the runner controls (38%).
There was no significant difference (P > 0,05) in reported
recreational fresh-water contact during the 1989/90 season
between the triathletes (85%) and the control runners (80%).
The seasonal incidence of schistosomiasis in the triathletes
was 64%.
Discussion
The results of this study show that triathletes in Zimbabwe
who swim in the open fresh-water dams have a significant
risk of contracting schistosomiasis during the season. The
high prevalence rate we documented in triathletes after the
1989/90 season (80%) is probably related to the infection
risk posed by: (I) the extra two dam swims during that
season; and (if) the high frequency of reported recreational
fresh-water contact.
The prevalence of schistosomiasis in these triathletes is
much higher than that reported in canoeists after the 1988
and 1989 Duzi canoe marathons in NataL'· The possible
reasons for this are: (I) canoeists (unlike triathletes) do not
immerse their whole bodies in the water for any length of
time and are therefore not exposed to infested water to the
same degree as the triathletes in our study; (if) the Duzi is a
fast-flowing river and is located in a different geographical
area; and (iif) because only urine testing for ova was
conducted in the study on canoeists, significant under-
reporting of schistosomiasis could have taken place. The
prevalence of schistosomiasis in triathletes in our study is
similar to that reported in schoolchildren in Zimbabwe
(consistently above 60%'9).
In our study urine and stool microscopy for the detection
of ova produced a very low yield in relation to the number of
positive serological (BFAT) tests. This suggests either very
low levels of infection (Iow worm loads or single-sex
infections) or a degree of false-positive detection by
serological tests. Finally, the reason why 3 triathletes had a
positive BFAT 5 months after treatment may have been
contact with infested fresh water after the date of treatment,
or that insufficient time had elapsed for their antibody titres
to drop.
In summary, the high seasonal incidence (64%) of
schistosomiasis in triathletes during the 1990/91 season
indicates that the precautions taken by race organisers of
triathlons in Zimbabwe were not effective. We suggest that
these measures be reviewed and that triathlon swims. be
moved to open fresh-water sources that are not infested
with schistosomiasis. These recommendations should also
be considered in other areas where schistosomiasis is
endemic.
The authors thank the medical technologists atJ;:aboratory
Services for their help with all laboratory testing, Blair
Research Laboratory for water data, and the Zimbabwean
Triathlon Association for its assistance. '
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